Role for the p53 homologue p73 in E2F-1-induced apoptosis

被引:525
|
作者
Irwin, M
Marin, MC
Phillips, AC
Seelan, RS
Smith, DI
Liu, WG
Flores, ER
Tsai, KY
Jacks, T
Vousden, KH
Kaelin, WG
机构
[1] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Brigham & Womens Hosp, Boston, MA 02115 USA
[3] NCI, Regulat Cell Growth Lab, FCRDC, Frederick, MD 21702 USA
[4] Mayo Clin & Mayo Fdn, Mayo Med Sch, Dept Lab Med & Pathol, Rochester, MN 55905 USA
[5] MIT, Dept Biol, Cambridge, MA 02139 USA
[6] MIT, Ctr Canc Res, Cambridge, MA 02139 USA
[7] Howard Hughes Med Inst, Chevy Chase, MD 20185 USA
关键词
D O I
10.1038/35036614
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The transcription factor E2F-1 induces both cell-cycle progression and, in certain settings, apoptosis. E2F-1 uses both p53-dependent and p53-independent pathways to kill cells(1-8). The p53-dependent pathway involves the induction by E2F-1 of the human tumour-suppressor protein p14ARF, which neutralizes HDM2 (human homologue of MDM2) and thereby stabilizes the p53 protein(9). Here we show that E2F-1 induces the transcription of the p53 homologue p73. Disruption of p73 function inhibited E2F-1-induced apoptosis in p53-defective tumour cells and in p53(-/-) mouse embryo fibroblasts. We conclude that activation of p73 provides a means for E2F-1 to induce death in the absence of p53.
引用
收藏
页码:645 / 648
页数:5
相关论文
共 50 条
  • [21] BTK modulates p73 activity to induce apoptosis independently of p53
    Miran Rada
    Nickolai Barlev
    Salvador Macip
    Cell Death Discovery, 4
  • [22] Examining the role of p73, a p53 homolog, in skin carcinogenesis
    Liefer, K
    Wang, X
    Yang, A
    McKeon, F
    Roop, D
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1999, 112 (04) : 558 - 558
  • [23] BTK modulates p73 activity to induce apoptosis independently of p53
    Rada, Miran
    Barlev, Nickolai
    Macip, Salvador
    CELL DEATH DISCOVERY, 2018, 4
  • [24] Degree of apoptosis induced by adenovirus-mediated transduction of p53 or p73α depends on the p53 status of glioma cells
    Shinoura, N
    Muramatsu, Y
    Asai, A
    Han, SY
    Horii, A
    Kirino, T
    Hamada, H
    CANCER LETTERS, 2000, 160 (01) : 67 - 73
  • [25] New monoclonal antibodies recognizing the p53 tumour suppressor protein homologue p73
    Cesková, P
    Nenutil, R
    Bray, S
    Svitáková, M
    Babcanová, S
    Uldrijan, S
    Vojtesek, B
    FOLIA BIOLOGICA, 2001, 47 (06) : 211 - 214
  • [26] P73, the new P53 homologue, is not involved in the pathogenesis of cutaneous malignant melanomas.
    Kroiss, MM
    Bosserhoff, AK
    Vogt, T
    Bogenrieder, T
    Landthaler, M
    Stolz, W
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1998, 110 (04) : 611 - 611
  • [27] Cooperation between p53 and p73 in cisplatin-induced apoptosis in ovarian carcinoma cells
    Righetti, Sabina Carla
    Perego, Paola
    Carenini, Nives
    Zunino, Franco
    CANCER LETTERS, 2008, 263 (01) : 140 - 144
  • [28] Inactivation of the p53-homologue p73 by the mdm2-oncoprotein
    Matthias Dobbelstein
    Sandra Wienzek
    Claudia König
    Judith Roth
    Oncogene, 1999, 18 : 2101 - 2106
  • [29] p63 and p73, the Ancestors of p53
    Doetsch, V.
    Bernassola, F.
    Coutandin, D.
    Candi, E.
    Melino, G.
    COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY, 2010, 2 (09): : a004887
  • [30] From p53 to p63 and p73
    不详
    TRENDS IN GENETICS, 1999, 15 (06) : 222 - 222